Etanercept in the treatment of ankylosing spondylitis: A randomized, double-blind, placebo-controlled study.

被引：0
|
作者：
Gorman, JD
Sack, KE
Davis, JC
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2000年 / 43卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2020
引用
收藏
页码：S403 / S403
页数：1
相关论文
共 50 条
  • [21] The effects of nanocurcumin on Treg cell responses and treatment of ankylosing spondylitis patients: A randomized, double-blind, placebo-controlled clinical trial
    Ahmadi, Majid
    Hajialilo, Mehrzad
    Dolati, Sanam
    Eghbal-Fard, Shadi
    Heydarlou, Hanieh
    Ghaebi, Mahnaz
    Ghassembaglou, Arezou
    Aghebati-Maleki, Leili
    Kafil, Hossein Samadi
    Kamrani, Amin
    Rahnama, Badrossadat
    Rikhtegar, Reza
    Yousefi, Mehdi
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2020, 121 (01) : 103 - 110
  • [22] Efficacy and Safety of Tofacitinib in Ankylosing Spondylitis: A Randomised, Double-blind, Placebo-controlled Trial
    Harish, B., V
    Sahoo, Rasmi Ranjan
    Gochhait, Samanyoya
    Patro, Pradeepta Sekhar
    INDIAN JOURNAL OF RHEUMATOLOGY, 2025, 20 (01) : 27 - 34
  • [23] Efficacy and safety of adalimumab in patients with ankylosing spondylitis - Results of a multicenter, randomized, double-blind, placebo-controlled trial
    van der Heijde, Desiree
    Kivitz, Alan
    Schiff, Michael H.
    Sieper, Joachim
    Dijkmans, Ben A. C.
    Braun, Juergen
    Dougados, Maxime
    Reveille, John D.
    Wong, Robert L.
    Kupper, Hartmut
    Davis, John C., Jr.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (07): : 2136 - 2146
  • [24] A Randomized, Double-Blind, Placebo-Controlled Phase 2a Study of Tildrakizumab Efficacy and Safety in Patients With Active Ankylosing Spondylitis
    Peters, Eric
    Chou, Richard C.
    Rozzo, Stephen J.
    Yao, Siu-Long
    Fructuoso, Ferran Jose Garcia
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023, 29 (05) : 223 - 229
  • [25] Alendronate Effect on the Prevention of Bone loss in Early Stages of Ankylosing Spondylitis: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
    Khabbazi, Alireza
    Noshad, Hamid
    Gafarzadeh, Sevil
    Hajialiloo, Mehrzad
    Kolahi, Susan
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2014, 16 (06)
  • [26] Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE)
    Dougados, M.
    Braun, J.
    Szanto, S.
    Combe, B.
    Elbaz, M.
    Geher, P.
    Thabut, G.
    Leblanc, V.
    Logeart, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (05) : 799 - 804
  • [27] Guaifenesin as treatment for fibromyalgia: A 1 year double-blind, placebo-controlled study.
    不详
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 2 - 2
  • [28] Double Blind, Placebo-Controlled Trial with Adalimumab for Treatment of Juvenile Ankylosing Spondylitis (JAS).
    Horneff, Gerd
    Fitter, Sigrid
    Huppertz, Hans-Iko
    Foeldvari, Ivan
    Kuemmerle-Deschner, Jasmin B.
    Kuester, Rolf M.
    Tzaribachev, Nikolay
    Thon, Angelika
    Borte, Michael
    Ganser, Gerd
    Trauzeddel, Ralf
    Minden, Kirsten
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S1030 - S1031
  • [29] A double blind placebo controlled trial of etanercept in the prevention of work disability in ankylosing spondylitis
    Barkham, Nick
    Coates, Laura
    Keen, Helen
    Hensor, Elizabeth
    Fraser, Alexander
    Redmond, Anthony
    Cawkswell, Lorna
    Emery, Paul
    RHEUMATOLOGY, 2008, 47 : II72 - II72
  • [30] Assessment of clinical efficacy in a randomized, double-blind study of etanercept and sulphasalazine in patients with ankylosing spondylitis
    Braun, J.
    Huang, F.
    Burgos-Vargas, R.
    van der Horst-Bruinsma, I. E.
    Freundlich, B.
    Vlahos, B.
    Koenig, A. S.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S415 - S415
12345